ImportanceDespite guidelines recommending against prostate-specific antigen (PSA) screening in elderly men with limited life expectancy, PSA screening remains common.ObjectiveTo identify clinician characteristics associated with PSA screening rates in older veterans stratified by life expectancy.Design, setting, and participantsCross-sectional study of 826 286 veterans 65 years or older eligible for PSA screening who had VA laboratory tests performed in 2011 in the VA health care system.Main outcomes and measuresThe primary outcome was the percentage of men with a screening PSA test in 2011. Limited life expectancy was defined as age of at least 85 years with Charlson comorbidity score of 1 or greater or age of at least 65 years with Charls...
Background: In 2008, the United States Preventive Services Task Force recommended against prostate s...
IntroductionIn 2008, the US Preventive Services Task Force (USPSTF) updated prostate cancer screenin...
© 2014 American Cancer Society. BACKGROUND: Prostate-specific antigen (PSA) screening for prostate c...
ImportanceDespite ongoing controversies surrounding prostate-specific antigen (PSA) screening, many ...
Background: Controversy surrounds prostate-specific antigen (PSA) testing for prostate cancer screen...
A single early prostate-specific antigen (PSA) level has been correlated with a higher likelihood of...
PURPOSE: To discuss the issue of screening for prostate cancer in elderly individuals. The impact of...
BackgroundProstate-specific antigen (PSA) screening for prostate cancer has high risks of overdiagno...
BackgroundProstate-specific antigen (PSA) screening for prostate cancer has high risks of overdiagno...
In 2008, the United States Preventive Services Task Force recommended against prostate specific anti...
In 2008, the United States Preventive Services Task Force recommended against prostate specific anti...
levels are predictive of a future diagnosis of prostate cancer. To test the hypothesis that older me...
OBJECTIVES: To evaluate the effect of the 2008 U.S. Preventative Services Task Force recommendation ...
OBJECTIVES: To evaluate the effect of the 2008 U.S. Preventative Services Task Force recommendation ...
IntroductionIn 2008, the US Preventive Services Task Force (USPSTF) updated prostate cancer screenin...
Background: In 2008, the United States Preventive Services Task Force recommended against prostate s...
IntroductionIn 2008, the US Preventive Services Task Force (USPSTF) updated prostate cancer screenin...
© 2014 American Cancer Society. BACKGROUND: Prostate-specific antigen (PSA) screening for prostate c...
ImportanceDespite ongoing controversies surrounding prostate-specific antigen (PSA) screening, many ...
Background: Controversy surrounds prostate-specific antigen (PSA) testing for prostate cancer screen...
A single early prostate-specific antigen (PSA) level has been correlated with a higher likelihood of...
PURPOSE: To discuss the issue of screening for prostate cancer in elderly individuals. The impact of...
BackgroundProstate-specific antigen (PSA) screening for prostate cancer has high risks of overdiagno...
BackgroundProstate-specific antigen (PSA) screening for prostate cancer has high risks of overdiagno...
In 2008, the United States Preventive Services Task Force recommended against prostate specific anti...
In 2008, the United States Preventive Services Task Force recommended against prostate specific anti...
levels are predictive of a future diagnosis of prostate cancer. To test the hypothesis that older me...
OBJECTIVES: To evaluate the effect of the 2008 U.S. Preventative Services Task Force recommendation ...
OBJECTIVES: To evaluate the effect of the 2008 U.S. Preventative Services Task Force recommendation ...
IntroductionIn 2008, the US Preventive Services Task Force (USPSTF) updated prostate cancer screenin...
Background: In 2008, the United States Preventive Services Task Force recommended against prostate s...
IntroductionIn 2008, the US Preventive Services Task Force (USPSTF) updated prostate cancer screenin...
© 2014 American Cancer Society. BACKGROUND: Prostate-specific antigen (PSA) screening for prostate c...